ChinaDaily Briefs

Daily Brief China: Anta Sports Products, ZJLD Group, Hang Seng China Enterprises Index, ADICON Holdings Limited, Health And Happiness (H&H) and more

In today’s briefing:

  • Anta Sports Placement – A Large Deal to Digest with Unknown Use of Proceeds but Track Record Is Good
  • ZJLD Group IPO – Sentiment Could See a Positive Shift, Mid-Bottom End Digestible
  • ZJLD Group IPO: Valuation Insights
  • Hang Seng CEI (HSCEI) – Pending Confirmation of Bullish Breakout and Textbook 7770/80 Q2 2023 Target
  • ADICON Holdings IPO: The Bull Case
  • Morning Views Asia: Guangzhou R&F Properties

Anta Sports Placement – A Large Deal to Digest with Unknown Use of Proceeds but Track Record Is Good

By Sumeet Singh

  • Anta Sports Products (2020 HK)  aims to raise around US$1.5bn in its top-up placement. 
  • Anta hasn’t specified what it aims to do with the money that it’s looking to raise, furthermore, it’s already net cash.
  • In this note, we will talk about the placement and run the deal through our ECM framework.

ZJLD Group IPO – Sentiment Could See a Positive Shift, Mid-Bottom End Digestible

By Clarence Chu

  • ZJLD Group (ZJLD HK) is looking to raise around US$811m in its Hong Kong IPO.
  • ZJLD Group (ZJLD) is a Chinese liquor company primarily producing baijiu.
  • In this note, we will look at deal dynamics and share our thoughts on valuation.

ZJLD Group IPO: Valuation Insights

By Arun George


Hang Seng CEI (HSCEI) – Pending Confirmation of Bullish Breakout and Textbook 7770/80 Q2 2023 Target

By David Coloretti, CMT

  • At TMA we deliver high probability outcomes by focusing on our 3 pillars of technical analysis. 1) Response to key levels. 2) Price action. 3) Momentum confirmation.
  • A prominent bottom below 5000 in Q4 2022 set up an impulsive multi-month uptrend and LT uptrend bias. Our 2023 target at 9450/70 reflects this major bottom.
  • 2023 has delivered a tangible downward correction. Since mid-February a Head and Shoulders Bottom has formed. A break above the neckline at 7085 targets 7770/80 in Q2 2023.

ADICON Holdings IPO: The Bull Case

By Arun George

  • ADICON Holdings Limited (ADI HK) is pre-marketing an HKEx IPO to raise up to US$400 million, according to press reports.
  • Adicon is the third largest independent clinical laboratories (ICL) service provider in China, with an 8.6% market share of the non-COVID-19 testing market in 2021, according to Frost & Sullivan.
  • The key elements of the bull case rest on the growing non-COVID-19 testing addressable market, improving market sentiment, strong non-COVID-19 testing growth, stable EBITDA margin and cash generation. 

Morning Views Asia: Guangzhou R&F Properties

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars